Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-07-13
1980-12-16
Schafer, Richard E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 435 7, 424 12, 260112B, G01N 3316, A61K 3900
Patent
active
042397430
ABSTRACT:
A fission product of an immunoglobulin having an immunologically functioning Fc-portion is bound to a carrier by adhesion or a chemical reaction. It can be used in an immunological analytic process for the determination of Fc-reactants in aqueous solutions.
REFERENCES:
patent: 3966898 (1976-06-01), Sjoquist et al.
patent: 4138213 (1979-02-01), Masson et al.
patent: 4143124 (1979-03-01), Masson et al.
Sedlacek Hans H.
Seiler Friedrich R.
Behringwerke Aktiengesellschaft
Nucker Christine M.
Schafer Richard E.
LandOfFree
Carrier-bound immunoglobulin fission product and its use in immu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carrier-bound immunoglobulin fission product and its use in immu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carrier-bound immunoglobulin fission product and its use in immu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-607710